Stock OWCP OWC PHARMACEUTICAL RESEARCH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights OWC Pharmaceutical Research Corp.

Equities

OWCP

US67109N1081

Delayed OTC Markets
Other stock markets
 09:30:00 2024-05-01 am EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for OWC Pharmaceutical Research Corp. 0.00% 0.00%
2021 OWC Pharmaceutical Research Corp. Announces Resignation of David Kugelman as the Sole Director CI
2021 Discover Growth Enters into Agreement with OWC Pharmaceutical CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
OWC Pharmaceutical Research Corp. Announces New Distribution Agreement with Can It Industries
CI
Owc Pharmaceutical Research Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019
CI
Stenocare A/S and Owc Pharmaceutical Research Corp. Enters into Partnership to Develop Advanced Medical Cannabis Products
CI
Owc Pharmaceutical Research Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019
CI
OWC Pharmaceuticals Research Receives Permit for Cannabis Based Ointment Efficacy Trial
CI
OWC Pharmaceuticals Research Corp. Receives Approval from Israeli Medical Cannabis Agency
CI
Owc Pharmaceutical Research Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019
CI
OWC Pharmaceutical Research Corp. Reports Earnings Results for the Full Year Ended December 31, 2018
CI
OWC Pharmaceutical Research Corp. to Collaborate with Sourasky Medical Center in Tel Aviv for a Safety Study on its Cannabis-Based Tablets
CI
OWC Pharmaceutical Research Corp. Reports Positive Phase 1 Safety Data for its Medical Grade Cannabis MSG Ointment for the Treatment of Skin Diseases
CI
OWC Pharmaceutical Research Corp. Reports the Successful Production of Cannabinoid-Enriched Sublingual Disintegrating Tablet
CI
OWC Pharmaceutical Research Corp. to Report Progress in Clinical Trials for Ointment Care for Skin Diseases
CI
OWC Pharmaceutical Research Corp Successfully Tests Unique, Innovative Delivery Formulation Aimed At Multiple Myeloma Therapy
CI
OWC Pharmaceutical Research Corp. Initiated Final Stage of Cannabinoid-Based Topical Ointment Safety Study
CI
OWC Pharmaceutical Research Corp Completes Development of Next Generation Orally-Disintegrating Tablet
CI
OWC Pharmaceutical Research Corp. Announces Update on its Proprietary Medical Cannabis Sublingual Tablet
CI
OWC Pharmaceutical Research Corp Releases Promising Preliminary Results from Efficacy Tests of its Topical Cream
CI
OWC Pharmaceutical Research Corp. Receives IRB Approval to Initiate Safety Testing on Cannabinoid-Infused Cream for Treatment of Psoriasis
CI
OWC Pharmaceutical Research Corp Completes Development of its Medical Cannabis Sublingual Tablet
CI
OWC Pharmaceutical Research Corp Signs Agreement with Medmar LLC
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OWCP Stock
  4. News OWC Pharmaceutical Research Corp.
  5. Highlights